Showing results (1-10 of 120) with videos related to
Sort By:
Pageof 12
Seminars in Neurology|October 16, 2018
Ensuring Justice in Access to Investigational Neurological DrugsLisa Kearns, Alison Bateman-House, Arthur CaplanThe American Journal of Bioethics : AJOB|October 19, 2021
Helpful Lessons and Cautionary Tales: How Should COVID-19 Drug Development and Access Inform Approaches to Non-Pandemic Diseases?Holly Fernandez Lynch, Arthur Caplan, Patricia Furlong, et al.Annual Review of Genomics and Human Genetics|August 27, 2024
Somatic Gene Therapy: Ethics and AccessAlison Bateman-HouseAmerican Journal of Public Health|May 15, 2014
Bikes, helmets, and public health: decision-making when goods collideAlison Bateman-HouseTherapeutic Innovation & Regulatory Science|May 2, 2018
A Pilot Experiment in Responding to Individual Patient Requests for Compassionate Use of an Unapproved Drug: The Compassionate Use Advisory Committee (CompAC)Arthur Caplan, Alison Bateman-House, Joanne Waldstreicher, et al.AJOB Empirical Bioethics|April 10, 2019
Single-Patient Expanded Access Requests: IRB Professionals' Experiences and PerspectivesCarolyn Riley Chapman, Jenni A Shearston, Kelly McBride Folkers, et al.Therapeutic Innovation & Regulatory Science|September 21, 2018
Who Stands to Benefit? Right to Try Law Provisions and ImplicationsLisa Kearns, Alison Bateman-HouseNucleic Acid Therapeutics|November 19, 2021
Individualized Therapeutics Development for Rare Diseases: The Current Ethical Landscape and Policy ResponsesAlison Bateman-House, Lisa KearnsAmerican Journal of Public Health|June 20, 2020
Mandatory Bicycle Helmet Laws in the United States: Origins, Context, and ControversiesKathleen Bachynski, Alison Bateman-HouseTherapeutic Innovation & Regulatory Science|May 4, 2018
Improving Expanded Access in the United States: The Role of the Institutional Review BoardKelly McBride Folkers, Alison Bateman-HousePageof 12